학술논문

Phase I experience with rogaratinib in patients with head and neck cancer selected based on FGFR mRNA overexpression
Document Type
Journal
Source
ANNALS OF ONCOLOGY; OCT 2018, 29 p377-p377, 1p. Supplement: 8
Subject
Language
English
ISSN
15698041